Suppr超能文献

腹腔镜肝切除术治疗恶性肝肿瘤,为何开展得不多?

Laparoscopic liver resection for malignant liver tumors, why not more?

作者信息

Kwon Ik Soo, Yun Sung Su, Lee Dong Shick, Kim Hong Jin

机构信息

Department of General Surgery, Yeungnam University Medical Center, Daegu, Korea.

出版信息

J Korean Surg Soc. 2012 Jul;83(1):30-5. doi: 10.4174/jkss.2012.83.1.30. Epub 2012 Jun 26.

Abstract

PURPOSE

The precise role of laparoscopic liver resection in liver malignancies remains controversial despite an increasing number of publications that have used the laparoscopic resection of benign liver tumors. This study was performed to assess the feasibility, safety, and outcome of laparoscopic liver resection for malignant liver tumors.

METHODS

This study is a retrospective review of the profiles, pathology, surgery and outcome performed on 61 patients who had undergone laparoscopic liver resection for liver malignancies between January 2004 and March 2011.

RESULTS

Among the 61 patients, 34 patients had hepatocellular carcinoma (HCC), 24 patients had liver metastasis. The mean tumor size was 2.8 ± 2.0 cm (mean ± standard deviation). Tumors located at Couinaud segment number 2 to 8. The resection included 36 anatomical resections, 25 wedge resections. The mean surgical time was 209.7 ± 108.9 minutes. There was one operation that resulted in death. Postoperative complications occurred in 9 patients (14%). There were 2 conversions to laparotomy (3%). The mean postoperative hospital stay was 9.0 ± 4.4 days. Blood transfusion was needed in 11 patients (18%). The mean surgical margin was 1.3 ± 1.2 cm. The mean follow-up period was 18.1 ± 11.1 months. The three-year overall survival rate was 87% for patients with HCC and 95% for patients having liver metastases from colorectal cancer.

CONCLUSION

Even though laparoscopic liver resection requires a learning curve, it produced acceptable outcomes even in patients who had a malignant liver tumor. This study provides evidence to support further investigation and the establishment of laparoscopic liver resection for malignant liver tumors.

摘要

目的

尽管有越来越多关于腹腔镜切除良性肝肿瘤的文献发表,但腹腔镜肝切除在肝脏恶性肿瘤中的精确作用仍存在争议。本研究旨在评估腹腔镜肝切除治疗肝脏恶性肿瘤的可行性、安全性及疗效。

方法

本研究是一项回顾性分析,对2004年1月至2011年3月期间61例行腹腔镜肝切除治疗肝脏恶性肿瘤患者的资料、病理、手术及疗效进行分析。

结果

61例患者中,34例为肝细胞癌(HCC),24例为肝转移瘤。肿瘤平均大小为2.8±2.0cm(均值±标准差)。肿瘤位于肝Couinaud 2至8段。切除方式包括36例解剖性切除,25例楔形切除。平均手术时间为209.7±108.9分钟。有1例手术导致死亡。9例患者(14%)发生术后并发症。2例转为开腹手术(3%)。平均术后住院时间为9.0±4.4天。11例患者(18%)需要输血。平均手术切缘为1.3±1.2cm。平均随访时间为18.1±11.1个月。HCC患者的三年总生存率为87%,结直肠癌肝转移患者为95%。

结论

尽管腹腔镜肝切除需要一个学习曲线,但即使对于肝脏恶性肿瘤患者也能产生可接受的疗效。本研究为支持进一步研究及确立腹腔镜肝切除治疗肝脏恶性肿瘤提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4770/3392313/552dab7fcd49/jkss-83-30-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验